UCSF School of Medicine, San Francisco, CA 94121, USA.
Prog Cardiovasc Dis. 2013 May-Jun;55(6):511-23. doi: 10.1016/j.pcad.2013.03.010. Epub 2013 Apr 11.
Approximately one out of every five patients with cardiovascular disease (CVD) suffers from major depressive disorder (MDD). Both MDD and depressive symptoms are risk factors for CVD incidence, severity and outcomes. Great progress has been made in understanding potential mediators between MDD and CVD, particularly focusing on health behaviors. Investigators have also made considerable strides in the diagnosis and treatment of depression among patients with CVD. At the same time, many research questions remain. In what settings is depression screening most effective for patients with CVD? What is the optimal screening frequency? Which therapies are safe and effective? How can we better integrate the care of mental health conditions with that of CVD? How do we motivate depressed patients to change health behaviors? What technological tools can we use to improve care for depression? Gaining a more thorough understanding of the links between MDD and heart disease, and how best to diagnose and treat depression among these patients, has the potential to substantially reduce morbidity and mortality from CVD.
大约每 5 例心血管疾病 (CVD) 患者中就有 1 例患有重度抑郁症 (MDD)。MDD 和抑郁症状都是 CVD 发病率、严重程度和结局的危险因素。人们在理解 MDD 和 CVD 之间的潜在中介方面取得了重大进展,特别是侧重于健康行为。研究人员在 CVD 患者的抑郁诊断和治疗方面也取得了相当大的进展。与此同时,许多研究问题仍然存在。在哪些情况下对 CVD 患者进行抑郁筛查最有效?最佳筛查频率是多少?哪些疗法既安全又有效?我们如何更好地将心理健康状况的护理与 CVD 的护理结合起来?我们如何激励抑郁患者改变健康行为?我们可以使用哪些技术工具来改善对抑郁的护理?更深入地了解 MDD 和心脏病之间的联系,以及如何最好地诊断和治疗这些患者的抑郁症,有可能显著降低 CVD 的发病率和死亡率。